Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurofibromatosis 2 | 5 | 2021 | 364 | 2.720 |
Why?
|
Neuroma, Acoustic | 5 | 2020 | 441 | 2.160 |
Why?
|
Hearing Loss | 3 | 2021 | 711 | 1.360 |
Why?
|
Pregnancy Proteins | 4 | 2013 | 230 | 0.980 |
Why?
|
Ascites | 2 | 2019 | 343 | 0.970 |
Why?
|
Vascular Endothelial Growth Factor A | 12 | 2017 | 3502 | 0.960 |
Why?
|
Neovascularization, Pathologic | 13 | 2019 | 2713 | 0.880 |
Why?
|
Losartan | 3 | 2023 | 265 | 0.870 |
Why?
|
Neurilemmoma | 3 | 2022 | 523 | 0.850 |
Why?
|
Lymphokines | 4 | 2011 | 968 | 0.730 |
Why?
|
Cerebellopontine Angle | 1 | 2019 | 58 | 0.710 |
Why?
|
Neurofibromin 2 | 4 | 2020 | 266 | 0.630 |
Why?
|
Receptors, CXCR4 | 3 | 2011 | 735 | 0.620 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2017 | 127 | 0.610 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2011 | 643 | 0.570 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 1996 | 0.490 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2018 | 609 | 0.480 |
Why?
|
Neuropilin-1 | 2 | 2013 | 91 | 0.480 |
Why?
|
Stromal Cells | 1 | 2019 | 1358 | 0.470 |
Why?
|
Rectal Neoplasms | 2 | 2010 | 1125 | 0.410 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18345 | 0.410 |
Why?
|
Chemokine CXCL12 | 2 | 2011 | 470 | 0.400 |
Why?
|
Neoplasms, Experimental | 4 | 2016 | 1331 | 0.400 |
Why?
|
Chemokine CXCL6 | 1 | 2009 | 19 | 0.390 |
Why?
|
Neoplasm Proteins | 3 | 2017 | 3777 | 0.380 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3694 | 0.380 |
Why?
|
Glioblastoma | 7 | 2023 | 3352 | 0.370 |
Why?
|
Central Nervous System Neoplasms | 1 | 2017 | 870 | 0.360 |
Why?
|
Antineoplastic Agents | 6 | 2019 | 13732 | 0.350 |
Why?
|
Doxorubicin | 2 | 2012 | 2233 | 0.350 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 4737 | 0.340 |
Why?
|
Cell Line, Tumor | 15 | 2021 | 16943 | 0.320 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2004 | 1326 | 0.320 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2007 | 216 | 0.310 |
Why?
|
Mice | 27 | 2023 | 80995 | 0.280 |
Why?
|
Ribonuclease, Pancreatic | 2 | 2016 | 153 | 0.280 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2862 | 0.280 |
Why?
|
DNA Methylation | 2 | 2010 | 4085 | 0.270 |
Why?
|
Hearing | 2 | 2019 | 432 | 0.270 |
Why?
|
Angiogenesis Inhibitors | 5 | 2011 | 2075 | 0.270 |
Why?
|
Antibodies, Neoplasm | 2 | 2016 | 312 | 0.260 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2005 | 184 | 0.260 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3489 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2019 | 8674 | 0.250 |
Why?
|
Animals | 34 | 2023 | 170726 | 0.240 |
Why?
|
Ubiquitination | 1 | 2007 | 1016 | 0.230 |
Why?
|
Sciatic Nerve | 2 | 2017 | 622 | 0.230 |
Why?
|
Mice, Nude | 5 | 2017 | 3825 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 997 | 0.220 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 1777 | 0.220 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 43 | 0.210 |
Why?
|
Signal Transduction | 12 | 2018 | 23973 | 0.210 |
Why?
|
Luciferases | 2 | 2019 | 761 | 0.210 |
Why?
|
Nerve Regeneration | 2 | 2017 | 801 | 0.200 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2021 | 203 | 0.200 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2007 | 1472 | 0.200 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3071 | 0.190 |
Why?
|
Benzamides | 2 | 2020 | 1411 | 0.190 |
Why?
|
Rodentia | 1 | 2021 | 236 | 0.190 |
Why?
|
Endothelial Growth Factors | 2 | 2002 | 695 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 522 | 0.190 |
Why?
|
Cerebellar Neoplasms | 2 | 2016 | 607 | 0.180 |
Why?
|
Carcinoma | 1 | 2011 | 2325 | 0.180 |
Why?
|
Lymph Nodes | 1 | 2011 | 3433 | 0.180 |
Why?
|
Injections, Intraventricular | 1 | 2019 | 232 | 0.180 |
Why?
|
Medulloblastoma | 2 | 2016 | 721 | 0.180 |
Why?
|
Virus Assembly | 1 | 2019 | 144 | 0.180 |
Why?
|
Genes, Reporter | 2 | 2019 | 1608 | 0.180 |
Why?
|
Cell Proliferation | 3 | 2012 | 10800 | 0.170 |
Why?
|
Hearing Tests | 1 | 2019 | 129 | 0.170 |
Why?
|
Cerebellum | 2 | 2017 | 1491 | 0.170 |
Why?
|
Binding, Competitive | 1 | 2019 | 1209 | 0.160 |
Why?
|
Promoter Regions, Genetic | 2 | 2007 | 6046 | 0.160 |
Why?
|
MAP Kinase Signaling System | 2 | 2004 | 1589 | 0.160 |
Why?
|
Probiotics | 1 | 2021 | 342 | 0.160 |
Why?
|
Neoplasm Transplantation | 4 | 2013 | 2150 | 0.160 |
Why?
|
Blood Vessels | 4 | 2015 | 1162 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11317 | 0.160 |
Why?
|
Oxytocin | 1 | 2021 | 369 | 0.160 |
Why?
|
Antibodies, Monoclonal | 4 | 2009 | 9584 | 0.160 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3460 | 0.150 |
Why?
|
Morpholines | 1 | 2020 | 571 | 0.150 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2001 | 2611 | 0.150 |
Why?
|
Fluorescence | 1 | 2019 | 770 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2010 | 562 | 0.150 |
Why?
|
Edema | 2 | 2023 | 757 | 0.150 |
Why?
|
Stereotaxic Techniques | 1 | 2019 | 560 | 0.150 |
Why?
|
Cell Cycle Proteins | 2 | 2007 | 3503 | 0.150 |
Why?
|
Rotarod Performance Test | 1 | 2015 | 64 | 0.150 |
Why?
|
Capsid Proteins | 1 | 2019 | 475 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2021 | 758 | 0.140 |
Why?
|
Granuloma, Respiratory Tract | 1 | 2015 | 10 | 0.140 |
Why?
|
Cerebellar Diseases | 1 | 2017 | 225 | 0.140 |
Why?
|
Organ Culture Techniques | 1 | 2018 | 860 | 0.140 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 2529 | 0.140 |
Why?
|
Cell Growth Processes | 2 | 2006 | 411 | 0.140 |
Why?
|
Cell Hypoxia | 1 | 2017 | 684 | 0.130 |
Why?
|
Breast Neoplasms | 2 | 2012 | 20059 | 0.130 |
Why?
|
Apoptosis | 5 | 2012 | 10112 | 0.130 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2015 | 1206 | 0.130 |
Why?
|
Drug Synergism | 1 | 2019 | 1878 | 0.130 |
Why?
|
Antibodies, Bispecific | 1 | 2016 | 150 | 0.130 |
Why?
|
Second Messenger Systems | 1 | 2015 | 219 | 0.130 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2015 | 921 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2004 | 2960 | 0.120 |
Why?
|
Pyrimidines | 2 | 2020 | 2969 | 0.120 |
Why?
|
Mice, SCID | 7 | 2017 | 2842 | 0.120 |
Why?
|
Humans | 37 | 2022 | 715124 | 0.120 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1408 | 0.120 |
Why?
|
Antibodies | 3 | 2015 | 2445 | 0.120 |
Why?
|
Mice, Knockout | 7 | 2021 | 15260 | 0.120 |
Why?
|
Transfection | 4 | 2006 | 6143 | 0.120 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 932 | 0.120 |
Why?
|
Vesicular Transport Proteins | 1 | 2016 | 381 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2009 | 3994 | 0.120 |
Why?
|
Treatment Outcome | 6 | 2022 | 62186 | 0.120 |
Why?
|
Granuloma | 1 | 2015 | 330 | 0.120 |
Why?
|
Radiation Tolerance | 1 | 2015 | 510 | 0.120 |
Why?
|
Disease Progression | 6 | 2017 | 13302 | 0.110 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 651 | 0.110 |
Why?
|
Radiotherapy | 2 | 2018 | 1623 | 0.110 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5977 | 0.110 |
Why?
|
Muscular Atrophy | 1 | 2015 | 353 | 0.110 |
Why?
|
Lymphatic Metastasis | 2 | 2011 | 2971 | 0.110 |
Why?
|
Osteoarthritis, Knee | 1 | 2022 | 1221 | 0.110 |
Why?
|
Blotting, Western | 3 | 2012 | 5441 | 0.110 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 318 | 0.100 |
Why?
|
Receptors, CXCR | 1 | 2011 | 52 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1429 | 0.100 |
Why?
|
Macrophages | 2 | 2016 | 5805 | 0.100 |
Why?
|
Brain Neoplasms | 4 | 2010 | 8804 | 0.100 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1788 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5238 | 0.100 |
Why?
|
Cyclic AMP | 1 | 2015 | 1531 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 1 | 2005 | 2964 | 0.100 |
Why?
|
Lung Neoplasms | 3 | 2012 | 12567 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2119 | 0.100 |
Why?
|
Collagen | 1 | 2019 | 2687 | 0.100 |
Why?
|
Prognosis | 4 | 2019 | 29168 | 0.100 |
Why?
|
Basement Membrane | 2 | 2008 | 358 | 0.090 |
Why?
|
Collagen Type I | 1 | 2012 | 577 | 0.090 |
Why?
|
Lymphangiogenesis | 1 | 2011 | 185 | 0.090 |
Why?
|
Quinazolines | 1 | 2016 | 1424 | 0.090 |
Why?
|
Lamins | 1 | 2008 | 38 | 0.090 |
Why?
|
Kidney Neoplasms | 1 | 2005 | 4042 | 0.090 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2015 | 816 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 680 | 0.090 |
Why?
|
Angiopoietin-1 | 2 | 2005 | 123 | 0.080 |
Why?
|
Tumor Stem Cell Assay | 1 | 2007 | 122 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1673 | 0.080 |
Why?
|
Pia Mater | 1 | 2008 | 93 | 0.080 |
Why?
|
Leupeptins | 1 | 2007 | 142 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2012 | 2412 | 0.080 |
Why?
|
Phthalazines | 1 | 2010 | 363 | 0.080 |
Why?
|
Gene Expression | 3 | 2019 | 8010 | 0.080 |
Why?
|
Paracrine Communication | 2 | 2013 | 284 | 0.080 |
Why?
|
DNA Damage | 1 | 2018 | 2467 | 0.080 |
Why?
|
Nitric Oxide | 2 | 2008 | 2121 | 0.080 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2007 | 217 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 3050 | 0.080 |
Why?
|
Oxygen | 3 | 2015 | 4169 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1642 | 0.080 |
Why?
|
Tumor Burden | 1 | 2012 | 1914 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2668 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3563 | 0.070 |
Why?
|
Immunoenzyme Techniques | 1 | 2009 | 1848 | 0.070 |
Why?
|
Trophoblasts | 1 | 2007 | 215 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11766 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3970 | 0.070 |
Why?
|
Disease | 1 | 2011 | 703 | 0.070 |
Why?
|
HCT116 Cells | 1 | 2006 | 410 | 0.070 |
Why?
|
Extracellular Fluid | 1 | 2006 | 160 | 0.070 |
Why?
|
Capillary Permeability | 2 | 2006 | 856 | 0.070 |
Why?
|
Dimerization | 1 | 2006 | 908 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5535 | 0.060 |
Why?
|
Genes, Dominant | 2 | 2004 | 904 | 0.060 |
Why?
|
Interleukin-8 | 2 | 2004 | 698 | 0.060 |
Why?
|
Transplantation, Heterologous | 3 | 2013 | 2436 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11192 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4933 | 0.060 |
Why?
|
DNA, Complementary | 1 | 2007 | 2095 | 0.060 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2002 | 775 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5482 | 0.060 |
Why?
|
Female | 10 | 2021 | 377334 | 0.060 |
Why?
|
Antibodies, Neutralizing | 1 | 2012 | 1831 | 0.060 |
Why?
|
Cell Movement | 4 | 2015 | 5468 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3674 | 0.060 |
Why?
|
Tuberculosis | 1 | 2015 | 1796 | 0.060 |
Why?
|
Ubiquitin | 1 | 2007 | 864 | 0.060 |
Why?
|
Lymphatic Vessels | 1 | 2006 | 323 | 0.060 |
Why?
|
Up-Regulation | 2 | 2009 | 4353 | 0.060 |
Why?
|
Down-Regulation | 2 | 2007 | 3091 | 0.060 |
Why?
|
Models, Biological | 3 | 2015 | 9895 | 0.050 |
Why?
|
Blotting, Northern | 1 | 2004 | 1630 | 0.050 |
Why?
|
Lactobacillus plantarum | 1 | 2021 | 7 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6575 | 0.050 |
Why?
|
Glioma | 2 | 2008 | 3295 | 0.050 |
Why?
|
Melanoma, Experimental | 1 | 2005 | 564 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2005 | 702 | 0.050 |
Why?
|
HIV-1 | 1 | 2019 | 6784 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2019 | 6858 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2009 | 13292 | 0.050 |
Why?
|
Receptor, EphA1 | 1 | 2020 | 19 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 739 | 0.050 |
Why?
|
DNA Primers | 2 | 2003 | 2999 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2022 | 11285 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 508 | 0.050 |
Why?
|
Piperazines | 1 | 2011 | 2540 | 0.050 |
Why?
|
Precancerous Conditions | 1 | 2006 | 940 | 0.050 |
Why?
|
Neovascularization, Physiologic | 2 | 2005 | 1422 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2011 | 2234 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2004 | 7947 | 0.040 |
Why?
|
Neurofibromatoses | 1 | 2022 | 270 | 0.040 |
Why?
|
Cell Line | 2 | 2019 | 16680 | 0.040 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2002 | 542 | 0.040 |
Why?
|
Rabbits | 2 | 2015 | 5149 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 410 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 2 | 2013 | 569 | 0.040 |
Why?
|
Pericytes | 2 | 2015 | 259 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2867 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2007 | 1880 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9521 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2022 | 11900 | 0.040 |
Why?
|
Receptor, TIE-2 | 2 | 2010 | 188 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 56155 | 0.040 |
Why?
|
Neoplasms | 3 | 2011 | 20515 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8912 | 0.040 |
Why?
|
Prospective Studies | 1 | 2021 | 51181 | 0.040 |
Why?
|
Capsid | 1 | 2019 | 435 | 0.040 |
Why?
|
Adipocytes | 1 | 2003 | 1183 | 0.040 |
Why?
|
Protein Kinases | 1 | 2004 | 1681 | 0.040 |
Why?
|
Respiratory Transport | 1 | 2015 | 7 | 0.040 |
Why?
|
RNA Interference | 1 | 2005 | 3022 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2005 | 3933 | 0.040 |
Why?
|
Adolescent | 3 | 2021 | 84999 | 0.040 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2017 | 273 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2005 | 3614 | 0.040 |
Why?
|
Pharmacology, Clinical | 1 | 2015 | 20 | 0.040 |
Why?
|
Skin Neoplasms | 2 | 2022 | 5312 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1022 | 0.030 |
Why?
|
Male | 10 | 2021 | 351081 | 0.030 |
Why?
|
Feces | 1 | 2021 | 1382 | 0.030 |
Why?
|
Pharmacology | 1 | 2015 | 111 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2006 | 5098 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22936 | 0.030 |
Why?
|
International Agencies | 1 | 2015 | 242 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1381 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4091 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2015 | 211 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2021 | 1902 | 0.030 |
Why?
|
Base Sequence | 2 | 2003 | 13315 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2906 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6566 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2021 | 72255 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3251 | 0.030 |
Why?
|
Coloring Agents | 1 | 2015 | 555 | 0.030 |
Why?
|
Phosphorylation | 1 | 2004 | 8738 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2266 | 0.030 |
Why?
|
Pain Measurement | 1 | 2022 | 3509 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2016 | 727 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1949 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2008 | 5718 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 774 | 0.030 |
Why?
|
Necrosis | 1 | 2015 | 1650 | 0.030 |
Why?
|
Brain | 1 | 2018 | 25188 | 0.030 |
Why?
|
Virus Replication | 1 | 2019 | 2544 | 0.030 |
Why?
|
beta Catenin | 1 | 2016 | 1044 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2730 | 0.020 |
Why?
|
Benzylamines | 1 | 2011 | 229 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1709 | 0.020 |
Why?
|
Lymphatic System | 1 | 2011 | 257 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2011 | 273 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4250 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6538 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8042 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2010 | 906 | 0.020 |
Why?
|
Adult | 3 | 2018 | 212129 | 0.020 |
Why?
|
Middle Aged | 3 | 2018 | 214871 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2008 | 344 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2008 | 173 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2015 | 3311 | 0.020 |
Why?
|
Ligands | 1 | 2015 | 3332 | 0.020 |
Why?
|
Dacarbazine | 1 | 2010 | 588 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2015 | 1622 | 0.020 |
Why?
|
Homeodomain Proteins | 2 | 2008 | 2457 | 0.020 |
Why?
|
Hydrostatic Pressure | 1 | 2006 | 108 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2003 | 5000 | 0.020 |
Why?
|
omega-N-Methylarginine | 1 | 2005 | 119 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 1004 | 0.020 |
Why?
|
Cell Division | 2 | 2004 | 4739 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2003 | 11746 | 0.020 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2008 | 404 | 0.020 |
Why?
|
Ephrin-B2 | 1 | 2004 | 44 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2008 | 720 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2008 | 571 | 0.020 |
Why?
|
Cell Membrane | 1 | 2015 | 3912 | 0.020 |
Why?
|
Collagen Type IV | 1 | 2004 | 136 | 0.020 |
Why?
|
Diffusion Chambers, Culture | 1 | 2003 | 49 | 0.020 |
Why?
|
Tubulin | 1 | 2008 | 759 | 0.020 |
Why?
|
Gamma Rays | 1 | 2004 | 334 | 0.020 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2006 | 473 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 354 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2013 | 20101 | 0.010 |
Why?
|
Hyperplasia | 1 | 2006 | 1173 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2004 | 294 | 0.010 |
Why?
|
Neuroglia | 1 | 2008 | 920 | 0.010 |
Why?
|
Dipeptides | 1 | 2004 | 412 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2008 | 2860 | 0.010 |
Why?
|
Matrix Metalloproteinases | 1 | 2004 | 408 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 939 | 0.010 |
Why?
|
3T3 Cells | 1 | 2003 | 1125 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1764 | 0.010 |
Why?
|
Genes, erbB-2 | 1 | 2002 | 169 | 0.010 |
Why?
|
Neutralization Tests | 1 | 2003 | 757 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 11691 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 834 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 630 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10379 | 0.010 |
Why?
|
Gene Silencing | 1 | 2008 | 1615 | 0.010 |
Why?
|
Fluorescein Angiography | 1 | 2004 | 892 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2010 | 1854 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2010 | 8093 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13573 | 0.010 |
Why?
|
Antigens | 1 | 2004 | 1511 | 0.010 |
Why?
|
Isoenzymes | 1 | 2004 | 1810 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 864 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4434 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6230 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41181 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9765 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3803 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2006 | 3010 | 0.010 |
Why?
|
NF-kappa B | 1 | 2004 | 2579 | 0.010 |
Why?
|
Tissue Engineering | 1 | 2005 | 1851 | 0.010 |
Why?
|
Stem Cells | 1 | 2008 | 3589 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2003 | 1652 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2004 | 3215 | 0.010 |
Why?
|
Child | 1 | 2021 | 74146 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2005 | 3426 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20398 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9661 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15584 | 0.010 |
Why?
|
Neurons | 1 | 2008 | 9419 | 0.010 |
Why?
|
Transcription Factors | 1 | 2003 | 12047 | 0.000 |
Why?
|
Mutation | 1 | 2008 | 29442 | 0.000 |
Why?
|
Time Factors | 1 | 2004 | 41081 | 0.000 |
Why?
|
Aged | 1 | 2010 | 162674 | 0.000 |
Why?
|